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Figure S1
Figure S1. SBE sensitizes DDP-induced suppression of invasive growth in NSCLC cells in vitro (A) Wound healing assay demonstrating that treatment of SBE for 24 hours inhibited cell migration of A549 and H1299 in dose-dependent manner (from 0 to 160 µg/ml).
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(B) Further quantitative analysis of scar scratch test showing that SBE at low dose (40µg/ml) mildly arrested the motility of A549 and H1299 cells and DDP at low dose (2µg/ml) has no effects. However, Co-treatment of SBE (40µg/ml) with DDP (2µg/ml) significantly and synergistically blocked those cell migrations. 
